drugset / Trial / NCT01111292
Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia
RandomizedParallel-groupDouble-blindPrevention
Summary
This pilot, randomized phase I/II trial studies how well inositol works in preventing colorectal cancer in patients with abnormal cells (dysplasia) associated with inflammation of the colon (colitis). Patients with colitis-associated dysplasia may have an increased risk of developing colorectal cancer. Inositol is a vitamin-like substance that may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Timeline
- Start
- 2010-10
- Primary completion
- 2014-09
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Inositol | Small molecule | — | Oral |